Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others); Technology (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others); Application (Proteomics, Drug Development, Genomics); End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CRO's), and Geography
Report Code: TIPRE00005787 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET OVERVIEW
Immunoglobulins (Ig) are another name for antibodies (Ab). These are big, Y-shaped proteins produced predominantly by plasma cells in the bloodstream in response to pathogens like viruses and bacteria. Antibodies have the ability to recognise specific molecules associated with hazardous substances. Antibodies are employed in the treatment of non-Hodgkin lymphoma, asthma, psoriasis, macular degeneration, rheumatoid arthritis, hypercholesterolemia, Crohn's disease, and as well as in the diagnosis of these diseases.
MARKET SCOPE
The "Global Antibodies Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibodies market with detailed market segmentation by type, technology, application, end user, and geography. The report provides key statistics on the market status of the leading antibodies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the market is bifurcated into monoclonal antibodies, polyclonal antibodies, ADCs, and others
- Based on technology, the market is bifurcated into western blotting, flow cytometry, elisa, immunohistochemistry, immunofluorescence, immunoprecipitation, and others
- Based on application, the market is bifurcated into proteomics, drug development, and genomics
- Based on end user, the market is bifurcated into pharmaceutical and biotechnology companies, academic and research institutes, and CRO's
MARKET DYNAMICS
Drivers:
- Increasing funding on R&D activities
- Growing industry-academia collaboration
Restraints:
- Quality concerns and a lack of reproducible results
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibodies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antibodies market in these regions.
IMPACT OF COVID-19 ON ANTIBODIES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the antibodies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antibodies market are anticipated to lucrative growth opportunities in the future with the rising demand for health coach in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antibodies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Merck KGaA
- Cell Signaling Technology, Inc.
- BD
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- GenScript
- QIAGEN
- Affinity Biologicals, Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibodies Market - By Type
1.3.2 Antibodies Market - By Technology
1.3.3 Antibodies Market - By Application
1.3.4 Antibodies Market - By End-User
1.3.5 Antibodies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODIES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. POLYCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Polyclonal Antibodies Market Forecast and Analysis
7.5. ADCS
7.5.1. Overview
7.5.2. ADCs Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. WESTERN BLOTTING
8.3.1. Overview
8.3.2. Western Blotting Market Forecast and Analysis
8.4. FLOW CYTOMETRY
8.4.1. Overview
8.4.2. Flow Cytometry Market Forecast and Analysis
8.5. ELISA
8.5.1. Overview
8.5.2. ELISA Market Forecast and Analysis
8.6. IMMUNOHISTOCHEMISTRY
8.6.1. Overview
8.6.2. Immunohistochemistry Market Forecast and Analysis
8.7. IMMUNOFLUORESCENCE
8.7.1. Overview
8.7.2. Immunofluorescence Market Forecast and Analysis
8.8. IMMUNOPRECIPITATION
8.8.1. Overview
8.8.2. Immunoprecipitation Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROTEOMICS
9.3.1. Overview
9.3.2. Proteomics Market Forecast and Analysis
9.4. DRUG DEVELOPMENT
9.4.1. Overview
9.4.2. Drug Development Market Forecast and Analysis
9.5. GENOMICS
9.5.1. Overview
9.5.2. Genomics Market Forecast and Analysis
10. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Research Institutes Market Forecast and Analysis
10.5. CRO'S
10.5.1. Overview
10.5.2. CRO's Market Forecast and Analysis
11. ANTIBODIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antibodies Market Overview
11.1.2 North America Antibodies Market Forecasts and Analysis
11.1.3 North America Antibodies Market Forecasts and Analysis - By Type
11.1.4 North America Antibodies Market Forecasts and Analysis - By Technology
11.1.5 North America Antibodies Market Forecasts and Analysis - By Application
11.1.6 North America Antibodies Market Forecasts and Analysis - By End-User
11.1.7 North America Antibodies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antibodies Market
11.1.7.1.1 United States Antibodies Market by Type
11.1.7.1.2 United States Antibodies Market by Technology
11.1.7.1.3 United States Antibodies Market by Application
11.1.7.1.4 United States Antibodies Market by End-User
11.1.7.2 Canada Antibodies Market
11.1.7.2.1 Canada Antibodies Market by Type
11.1.7.2.2 Canada Antibodies Market by Technology
11.1.7.2.3 Canada Antibodies Market by Application
11.1.7.2.4 Canada Antibodies Market by End-User
11.1.7.3 Mexico Antibodies Market
11.1.7.3.1 Mexico Antibodies Market by Type
11.1.7.3.2 Mexico Antibodies Market by Technology
11.1.7.3.3 Mexico Antibodies Market by Application
11.1.7.3.4 Mexico Antibodies Market by End-User
11.2. EUROPE
11.2.1 Europe Antibodies Market Overview
11.2.2 Europe Antibodies Market Forecasts and Analysis
11.2.3 Europe Antibodies Market Forecasts and Analysis - By Type
11.2.4 Europe Antibodies Market Forecasts and Analysis - By Technology
11.2.5 Europe Antibodies Market Forecasts and Analysis - By Application
11.2.6 Europe Antibodies Market Forecasts and Analysis - By End-User
11.2.7 Europe Antibodies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antibodies Market
11.2.7.1.1 Germany Antibodies Market by Type
11.2.7.1.2 Germany Antibodies Market by Technology
11.2.7.1.3 Germany Antibodies Market by Application
11.2.7.1.4 Germany Antibodies Market by End-User
11.2.7.2 France Antibodies Market
11.2.7.2.1 France Antibodies Market by Type
11.2.7.2.2 France Antibodies Market by Technology
11.2.7.2.3 France Antibodies Market by Application
11.2.7.2.4 France Antibodies Market by End-User
11.2.7.3 Italy Antibodies Market
11.2.7.3.1 Italy Antibodies Market by Type
11.2.7.3.2 Italy Antibodies Market by Technology
11.2.7.3.3 Italy Antibodies Market by Application
11.2.7.3.4 Italy Antibodies Market by End-User
11.2.7.4 Spain Antibodies Market
11.2.7.4.1 Spain Antibodies Market by Type
11.2.7.4.2 Spain Antibodies Market by Technology
11.2.7.4.3 Spain Antibodies Market by Application
11.2.7.4.4 Spain Antibodies Market by End-User
11.2.7.5 United Kingdom Antibodies Market
11.2.7.5.1 United Kingdom Antibodies Market by Type
11.2.7.5.2 United Kingdom Antibodies Market by Technology
11.2.7.5.3 United Kingdom Antibodies Market by Application
11.2.7.5.4 United Kingdom Antibodies Market by End-User
11.2.7.6 Rest of Europe Antibodies Market
11.2.7.6.1 Rest of Europe Antibodies Market by Type
11.2.7.6.2 Rest of Europe Antibodies Market by Technology
11.2.7.6.3 Rest of Europe Antibodies Market by Application
11.2.7.6.4 Rest of Europe Antibodies Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antibodies Market Overview
11.3.2 Asia-Pacific Antibodies Market Forecasts and Analysis
11.3.3 Asia-Pacific Antibodies Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Antibodies Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Antibodies Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Antibodies Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Antibodies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antibodies Market
11.3.7.1.1 Australia Antibodies Market by Type
11.3.7.1.2 Australia Antibodies Market by Technology
11.3.7.1.3 Australia Antibodies Market by Application
11.3.7.1.4 Australia Antibodies Market by End-User
11.3.7.2 China Antibodies Market
11.3.7.2.1 China Antibodies Market by Type
11.3.7.2.2 China Antibodies Market by Technology
11.3.7.2.3 China Antibodies Market by Application
11.3.7.2.4 China Antibodies Market by End-User
11.3.7.3 India Antibodies Market
11.3.7.3.1 India Antibodies Market by Type
11.3.7.3.2 India Antibodies Market by Technology
11.3.7.3.3 India Antibodies Market by Application
11.3.7.3.4 India Antibodies Market by End-User
11.3.7.4 Japan Antibodies Market
11.3.7.4.1 Japan Antibodies Market by Type
11.3.7.4.2 Japan Antibodies Market by Technology
11.3.7.4.3 Japan Antibodies Market by Application
11.3.7.4.4 Japan Antibodies Market by End-User
11.3.7.5 South Korea Antibodies Market
11.3.7.5.1 South Korea Antibodies Market by Type
11.3.7.5.2 South Korea Antibodies Market by Technology
11.3.7.5.3 South Korea Antibodies Market by Application
11.3.7.5.4 South Korea Antibodies Market by End-User
11.3.7.6 Rest of Asia-Pacific Antibodies Market
11.3.7.6.1 Rest of Asia-Pacific Antibodies Market by Type
11.3.7.6.2 Rest of Asia-Pacific Antibodies Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Antibodies Market by Application
11.3.7.6.4 Rest of Asia-Pacific Antibodies Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antibodies Market Overview
11.4.2 Middle East and Africa Antibodies Market Forecasts and Analysis
11.4.3 Middle East and Africa Antibodies Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Antibodies Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Antibodies Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Antibodies Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Antibodies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antibodies Market
11.4.7.1.1 South Africa Antibodies Market by Type
11.4.7.1.2 South Africa Antibodies Market by Technology
11.4.7.1.3 South Africa Antibodies Market by Application
11.4.7.1.4 South Africa Antibodies Market by End-User
11.4.7.2 Saudi Arabia Antibodies Market
11.4.7.2.1 Saudi Arabia Antibodies Market by Type
11.4.7.2.2 Saudi Arabia Antibodies Market by Technology
11.4.7.2.3 Saudi Arabia Antibodies Market by Application
11.4.7.2.4 Saudi Arabia Antibodies Market by End-User
11.4.7.3 U.A.E Antibodies Market
11.4.7.3.1 U.A.E Antibodies Market by Type
11.4.7.3.2 U.A.E Antibodies Market by Technology
11.4.7.3.3 U.A.E Antibodies Market by Application
11.4.7.3.4 U.A.E Antibodies Market by End-User
11.4.7.4 Rest of Middle East and Africa Antibodies Market
11.4.7.4.1 Rest of Middle East and Africa Antibodies Market by Type
11.4.7.4.2 Rest of Middle East and Africa Antibodies Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Antibodies Market by Application
11.4.7.4.4 Rest of Middle East and Africa Antibodies Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antibodies Market Overview
11.5.2 South and Central America Antibodies Market Forecasts and Analysis
11.5.3 South and Central America Antibodies Market Forecasts and Analysis - By Type
11.5.4 South and Central America Antibodies Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Antibodies Market Forecasts and Analysis - By Application
11.5.6 South and Central America Antibodies Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Antibodies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antibodies Market
11.5.7.1.1 Brazil Antibodies Market by Type
11.5.7.1.2 Brazil Antibodies Market by Technology
11.5.7.1.3 Brazil Antibodies Market by Application
11.5.7.1.4 Brazil Antibodies Market by End-User
11.5.7.2 Argentina Antibodies Market
11.5.7.2.1 Argentina Antibodies Market by Type
11.5.7.2.2 Argentina Antibodies Market by Technology
11.5.7.2.3 Argentina Antibodies Market by Application
11.5.7.2.4 Argentina Antibodies Market by End-User
11.5.7.3 Rest of South and Central America Antibodies Market
11.5.7.3.1 Rest of South and Central America Antibodies Market by Type
11.5.7.3.2 Rest of South and Central America Antibodies Market by Technology
11.5.7.3.3 Rest of South and Central America Antibodies Market by Application
11.5.7.3.4 Rest of South and Central America Antibodies Market by End-User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBODIES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. ANTIBODIES MARKET, KEY COMPANY PROFILES
14.1. MERCK KGAA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. CELL SIGNALING TECHNOLOGY, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BD
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. F. HOFFMANN-LA ROCHE LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIO-RAD LABORATORIES, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AGILENT TECHNOLOGIES, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BECKMAN COULTER, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. GENSCRIPT
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. QIAGEN
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. AFFINITY BIOLOGICALS, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibodies Market - By Type
1.3.2 Antibodies Market - By Technology
1.3.3 Antibodies Market - By Application
1.3.4 Antibodies Market - By End-User
1.3.5 Antibodies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODIES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. POLYCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Polyclonal Antibodies Market Forecast and Analysis
7.5. ADCS
7.5.1. Overview
7.5.2. ADCs Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. WESTERN BLOTTING
8.3.1. Overview
8.3.2. Western Blotting Market Forecast and Analysis
8.4. FLOW CYTOMETRY
8.4.1. Overview
8.4.2. Flow Cytometry Market Forecast and Analysis
8.5. ELISA
8.5.1. Overview
8.5.2. ELISA Market Forecast and Analysis
8.6. IMMUNOHISTOCHEMISTRY
8.6.1. Overview
8.6.2. Immunohistochemistry Market Forecast and Analysis
8.7. IMMUNOFLUORESCENCE
8.7.1. Overview
8.7.2. Immunofluorescence Market Forecast and Analysis
8.8. IMMUNOPRECIPITATION
8.8.1. Overview
8.8.2. Immunoprecipitation Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROTEOMICS
9.3.1. Overview
9.3.2. Proteomics Market Forecast and Analysis
9.4. DRUG DEVELOPMENT
9.4.1. Overview
9.4.2. Drug Development Market Forecast and Analysis
9.5. GENOMICS
9.5.1. Overview
9.5.2. Genomics Market Forecast and Analysis
10. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Research Institutes Market Forecast and Analysis
10.5. CRO'S
10.5.1. Overview
10.5.2. CRO's Market Forecast and Analysis
11. ANTIBODIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antibodies Market Overview
11.1.2 North America Antibodies Market Forecasts and Analysis
11.1.3 North America Antibodies Market Forecasts and Analysis - By Type
11.1.4 North America Antibodies Market Forecasts and Analysis - By Technology
11.1.5 North America Antibodies Market Forecasts and Analysis - By Application
11.1.6 North America Antibodies Market Forecasts and Analysis - By End-User
11.1.7 North America Antibodies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antibodies Market
11.1.7.1.1 United States Antibodies Market by Type
11.1.7.1.2 United States Antibodies Market by Technology
11.1.7.1.3 United States Antibodies Market by Application
11.1.7.1.4 United States Antibodies Market by End-User
11.1.7.2 Canada Antibodies Market
11.1.7.2.1 Canada Antibodies Market by Type
11.1.7.2.2 Canada Antibodies Market by Technology
11.1.7.2.3 Canada Antibodies Market by Application
11.1.7.2.4 Canada Antibodies Market by End-User
11.1.7.3 Mexico Antibodies Market
11.1.7.3.1 Mexico Antibodies Market by Type
11.1.7.3.2 Mexico Antibodies Market by Technology
11.1.7.3.3 Mexico Antibodies Market by Application
11.1.7.3.4 Mexico Antibodies Market by End-User
11.2. EUROPE
11.2.1 Europe Antibodies Market Overview
11.2.2 Europe Antibodies Market Forecasts and Analysis
11.2.3 Europe Antibodies Market Forecasts and Analysis - By Type
11.2.4 Europe Antibodies Market Forecasts and Analysis - By Technology
11.2.5 Europe Antibodies Market Forecasts and Analysis - By Application
11.2.6 Europe Antibodies Market Forecasts and Analysis - By End-User
11.2.7 Europe Antibodies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antibodies Market
11.2.7.1.1 Germany Antibodies Market by Type
11.2.7.1.2 Germany Antibodies Market by Technology
11.2.7.1.3 Germany Antibodies Market by Application
11.2.7.1.4 Germany Antibodies Market by End-User
11.2.7.2 France Antibodies Market
11.2.7.2.1 France Antibodies Market by Type
11.2.7.2.2 France Antibodies Market by Technology
11.2.7.2.3 France Antibodies Market by Application
11.2.7.2.4 France Antibodies Market by End-User
11.2.7.3 Italy Antibodies Market
11.2.7.3.1 Italy Antibodies Market by Type
11.2.7.3.2 Italy Antibodies Market by Technology
11.2.7.3.3 Italy Antibodies Market by Application
11.2.7.3.4 Italy Antibodies Market by End-User
11.2.7.4 Spain Antibodies Market
11.2.7.4.1 Spain Antibodies Market by Type
11.2.7.4.2 Spain Antibodies Market by Technology
11.2.7.4.3 Spain Antibodies Market by Application
11.2.7.4.4 Spain Antibodies Market by End-User
11.2.7.5 United Kingdom Antibodies Market
11.2.7.5.1 United Kingdom Antibodies Market by Type
11.2.7.5.2 United Kingdom Antibodies Market by Technology
11.2.7.5.3 United Kingdom Antibodies Market by Application
11.2.7.5.4 United Kingdom Antibodies Market by End-User
11.2.7.6 Rest of Europe Antibodies Market
11.2.7.6.1 Rest of Europe Antibodies Market by Type
11.2.7.6.2 Rest of Europe Antibodies Market by Technology
11.2.7.6.3 Rest of Europe Antibodies Market by Application
11.2.7.6.4 Rest of Europe Antibodies Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antibodies Market Overview
11.3.2 Asia-Pacific Antibodies Market Forecasts and Analysis
11.3.3 Asia-Pacific Antibodies Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Antibodies Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Antibodies Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Antibodies Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Antibodies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antibodies Market
11.3.7.1.1 Australia Antibodies Market by Type
11.3.7.1.2 Australia Antibodies Market by Technology
11.3.7.1.3 Australia Antibodies Market by Application
11.3.7.1.4 Australia Antibodies Market by End-User
11.3.7.2 China Antibodies Market
11.3.7.2.1 China Antibodies Market by Type
11.3.7.2.2 China Antibodies Market by Technology
11.3.7.2.3 China Antibodies Market by Application
11.3.7.2.4 China Antibodies Market by End-User
11.3.7.3 India Antibodies Market
11.3.7.3.1 India Antibodies Market by Type
11.3.7.3.2 India Antibodies Market by Technology
11.3.7.3.3 India Antibodies Market by Application
11.3.7.3.4 India Antibodies Market by End-User
11.3.7.4 Japan Antibodies Market
11.3.7.4.1 Japan Antibodies Market by Type
11.3.7.4.2 Japan Antibodies Market by Technology
11.3.7.4.3 Japan Antibodies Market by Application
11.3.7.4.4 Japan Antibodies Market by End-User
11.3.7.5 South Korea Antibodies Market
11.3.7.5.1 South Korea Antibodies Market by Type
11.3.7.5.2 South Korea Antibodies Market by Technology
11.3.7.5.3 South Korea Antibodies Market by Application
11.3.7.5.4 South Korea Antibodies Market by End-User
11.3.7.6 Rest of Asia-Pacific Antibodies Market
11.3.7.6.1 Rest of Asia-Pacific Antibodies Market by Type
11.3.7.6.2 Rest of Asia-Pacific Antibodies Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Antibodies Market by Application
11.3.7.6.4 Rest of Asia-Pacific Antibodies Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antibodies Market Overview
11.4.2 Middle East and Africa Antibodies Market Forecasts and Analysis
11.4.3 Middle East and Africa Antibodies Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Antibodies Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Antibodies Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Antibodies Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Antibodies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antibodies Market
11.4.7.1.1 South Africa Antibodies Market by Type
11.4.7.1.2 South Africa Antibodies Market by Technology
11.4.7.1.3 South Africa Antibodies Market by Application
11.4.7.1.4 South Africa Antibodies Market by End-User
11.4.7.2 Saudi Arabia Antibodies Market
11.4.7.2.1 Saudi Arabia Antibodies Market by Type
11.4.7.2.2 Saudi Arabia Antibodies Market by Technology
11.4.7.2.3 Saudi Arabia Antibodies Market by Application
11.4.7.2.4 Saudi Arabia Antibodies Market by End-User
11.4.7.3 U.A.E Antibodies Market
11.4.7.3.1 U.A.E Antibodies Market by Type
11.4.7.3.2 U.A.E Antibodies Market by Technology
11.4.7.3.3 U.A.E Antibodies Market by Application
11.4.7.3.4 U.A.E Antibodies Market by End-User
11.4.7.4 Rest of Middle East and Africa Antibodies Market
11.4.7.4.1 Rest of Middle East and Africa Antibodies Market by Type
11.4.7.4.2 Rest of Middle East and Africa Antibodies Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Antibodies Market by Application
11.4.7.4.4 Rest of Middle East and Africa Antibodies Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antibodies Market Overview
11.5.2 South and Central America Antibodies Market Forecasts and Analysis
11.5.3 South and Central America Antibodies Market Forecasts and Analysis - By Type
11.5.4 South and Central America Antibodies Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Antibodies Market Forecasts and Analysis - By Application
11.5.6 South and Central America Antibodies Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Antibodies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antibodies Market
11.5.7.1.1 Brazil Antibodies Market by Type
11.5.7.1.2 Brazil Antibodies Market by Technology
11.5.7.1.3 Brazil Antibodies Market by Application
11.5.7.1.4 Brazil Antibodies Market by End-User
11.5.7.2 Argentina Antibodies Market
11.5.7.2.1 Argentina Antibodies Market by Type
11.5.7.2.2 Argentina Antibodies Market by Technology
11.5.7.2.3 Argentina Antibodies Market by Application
11.5.7.2.4 Argentina Antibodies Market by End-User
11.5.7.3 Rest of South and Central America Antibodies Market
11.5.7.3.1 Rest of South and Central America Antibodies Market by Type
11.5.7.3.2 Rest of South and Central America Antibodies Market by Technology
11.5.7.3.3 Rest of South and Central America Antibodies Market by Application
11.5.7.3.4 Rest of South and Central America Antibodies Market by End-User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBODIES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. ANTIBODIES MARKET, KEY COMPANY PROFILES
14.1. MERCK KGAA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. CELL SIGNALING TECHNOLOGY, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BD
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. F. HOFFMANN-LA ROCHE LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIO-RAD LABORATORIES, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AGILENT TECHNOLOGIES, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BECKMAN COULTER, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. GENSCRIPT
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. QIAGEN
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. AFFINITY BIOLOGICALS, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Merck KGaA
2. Cell Signalling Technology, Inc.
3. BD
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies, Inc.
7. Beckman Coulter, Inc.
8. GenScript
9. QIAGEN
10. Affinity Biologicals, Inc.
11. BioLegend
12. Lonza
13. PerkinElmer
14. Danaher Corporation
15. Abcam Plc
16. Thermo Fisher Scientific, Inc.
1. Merck KGaA
2. Cell Signalling Technology, Inc.
3. BD
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies, Inc.
7. Beckman Coulter, Inc.
8. GenScript
9. QIAGEN
10. Affinity Biologicals, Inc.
11. BioLegend
12. Lonza
13. PerkinElmer
14. Danaher Corporation
15. Abcam Plc
16. Thermo Fisher Scientific, Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount